BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30902562)

  • 1. Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer.
    Lee J; Lee J; Kim JH
    Cancer Lett; 2019 Aug; 456():1-12. PubMed ID: 30902562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A.
    Lee J; Lee J; Yun JH; Choi C; Cho S; Kim SJ; Kim JH
    Sci Rep; 2017 Oct; 7(1):12760. PubMed ID: 28986588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells.
    Lee J; Hun Yun J; Lee J; Choi C; Hoon Kim J
    Sci Rep; 2015 Jul; 5():12296. PubMed ID: 26212664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
    Lee J; Lee J; Yun JH; Jeong DG; Kim JH
    Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DUSP28 promotes cell proliferation, migration, and invasion by Akt/β-catenin/Slug axis in breast cancer.
    Zhang J; Guo Y
    Acta Biochim Pol; 2022 Dec; 69(4):711-717. PubMed ID: 36520087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.
    He T; Qi F; Jia L; Wang S; Wang C; Song N; Fu Y; Li L; Luo Y
    Cancer Lett; 2015 Nov; 368(1):115-125. PubMed ID: 26272182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer" [Cancer Lett. 456 (2019 Aug 1) 1-12].
    Lee J; Lee J; Kim JH
    Cancer Lett; 2024 Feb; 583():216454. PubMed ID: 38044256
    [No Abstract]   [Full Text] [Related]  

  • 8. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.
    Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T
    Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling.
    Wang D; Han S; Peng R; Jiao C; Wang X; Han Z; Li X
    Int J Oncol; 2014 Dec; 45(6):2596-604. PubMed ID: 25230705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
    Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
    Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5.
    Echavarria R; Hussain SN
    J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.
    Oria VO; Lopatta P; Schmitz T; Preca BT; Nyström A; Conrad C; Bartsch JW; Kulemann B; Hoeppner J; Maurer J; Bronsert P; Schilling O
    Mol Oncol; 2019 Feb; 13(2):456-479. PubMed ID: 30556643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28.
    Ku B; Hong W; Keum CW; Kim M; Ryu H; Jeon D; Shin HC; Kim JH; Kim SJ; Ryu SE
    PLoS One; 2017; 12(11):e0187701. PubMed ID: 29121083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways.
    Wu Y; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu M; Jin H
    Exp Cell Res; 2019 Jun; 379(1):30-47. PubMed ID: 30894280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer.
    Xin B; He X; Wang J; Cai J; Wei W; Zhang T; Shen X
    Pancreatology; 2016; 16(6):1005-1014. PubMed ID: 27654574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
    Lee Y; Kim SJ; Park HD; Park EH; Huang SM; Jeon SB; Kim JM; Lim DS; Koh SS
    Oncogene; 2010 Jan; 29(1):56-67. PubMed ID: 19784070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways.
    Chen Q; Yang C; Chen L; Zhang JJ; Ge WL; Yuan H; Meng LD; Huang XM; Shen P; Miao Y; Jiang KR
    Br J Cancer; 2019 Nov; 121(11):912-921. PubMed ID: 31631174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
    Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
    Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling.
    Du S; Yang Z; Lu X; Yousuf S; Zhao M; Li W; Miao J; Wang X; Yu H; Zhu X; Chen H; Shi L; Xu E; Xia X; Guan W
    Oncogene; 2021 Sep; 40(38):5764-5779. PubMed ID: 34341514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment.
    Guo Q; Yang J; Chen Y; Jin X; Li Z; Wen X; Xia Q; Wang Y
    Eur J Pharmacol; 2020 Oct; 884():173394. PubMed ID: 32730833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.